Loading provider…
Loading provider…
Specialist in Sleepy Hollow, NY
NPI: 1730242124HQ Phone
Get M.D. Janice's Phone Numberphone_androidMobile
Get M.D. Janice's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
1982 - 2025
MD State Medical License
1978 - 2018
IL State Medical License
1976 - 1984
NY State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 1975
National Institutes of Health Clinical Center
Fellowship • Hematology and Medical Oncology
1978 - 1981
Rush University Medical Center
Residency • Internal Medicine
1976 - 1978
Internship • Internal Medicine
1975 - 1976
University of Utah
BA • Magna Cum Laude
Until 1971
Localization of infection using Indium-labelled granulocytes in granulocytopenic patients.
Authors: Oyen, W J, Claessens, R A, Raemaekers, J M, de Pauw, B E, van der Meer, J W, Corstens, F H
Journal: J Clin Oncol
Lead Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: bevacizumab, BIOLOGICAL: aldesleukin
Lead Sponsor: Our Lady of Mercy Medical Center
Intervention / Treatment: DRUG: arsenic trioxide
Lead Sponsor: Beth Israel Deaconess Medical Center
Collaborators: Vanderbilt University, University of California, Los Angeles, University of Cincinnati, Indiana University, University of Pittsburgh, University of Virginia, Dana-Farber Cancer Institute, Loyola University, Dartmouth-Hitchcock Medical Center, Roswell Park Cancer Institute, Wayne State University, City of Hope National Medical Center, Providence Cancer Center, Earle A. Chiles Research Institute, Our Lady of Mercy Medical Center
Intervention / Treatment: DRUG: HD IL2